FB 04 - Universitätsmedizin
Johannes Gutenberg-Universität Mainz
Obere Zahlbacher Str. 63, Geb. 912, 55131 Mainz
- 06131/17-9704 oder 9799 (Sekretariat)
- 06131/17-9669
Forschungsprojekte
Ergebnisse pro Seite:
10
2022 - 2025
Untreated distal Hypospadias - Natural history of the foreskin- Prof. Dr. AnnetteSchröder
2022 - 2026
Exploring KrasG12V-specific TCR-like CAR redirected T cells for immunotherapy in non-small cell lung cancer (NSCLC)- PD Dr. UdoHartwig
2022 - 2026
Targeting chromatin complexes to reverse AML immune escape for engineered cell therapy (SFB 1292/2, TP 12)- Dr. MichaelKühn,
- Prof. Dr. EvelynUllrich
2022 - 2040
International phase III, open label, multi-centre, randomised, collaborative treatment optimizing Trial (#1419)- Dr. MariusFried
2022 - 2025
Lebensqualität von Patienten und deren Bettpartnern vor und nach Implantation eines Hypoglossus-Neurostimulators (HGNS)- Prof. Dr. HaralamposGouveris
2022 - 2040
A Phase 3 Study of the Hepcidin Mimetic Rusfertide (PTG-300) in Patients with Polycythemia Vera (#1418)- Prof. Dr. MarkusRadsak
2022 - 2026
A Phase III Randomized, Open-Label, Multicenter Study to Determine the Efficacy and Safety of Durvalumab in Combination With Tremelimumab and Enfortumab Vedotin or Durvalumab in Combination With Enfortumab Vedotin for Perioperative Treatment in Patients Ineligible for Cisplatin or Who Refuse Cisplatin Undergoing Radical Cystectomy for Muscle InvasiveBladder Cancer (VOLGA)- PD Dr. med. MaximilianBrandt,
- PD Dr. ReneMager,
- Dr. AnitaThomas
2022 - 2025
Kompatibilität und Stabilität von applikationsfertigen Parenteralia- Prof. Dr. IreneKrämer,
- ZoeMittmann,
- Dr. JudithThiesen
2022 - 2027
Analysis of antibody responses against tumor-derived neo-antigens in triple-negative breast cancer (TNBC)- Univ.-Prof. Dr. MarcusSchmidt,
- PD Dr. Anne-SophieHeimes